SpliSense is an Israel-based biopharmaceutical company that develops and commercializes mRNA therapies for the treatment of cystic fibrosis and genetic pulmonary diseases.
Business Model:
Revenue: $2M
Employees: 11-50
Address: Edmond Safra Campus
City: Jerusalem
State: jerusalem district
Zip: 9190401
Country: IL
SpliSense is an Israel-based biopharmaceutical company that develops and commercializes mRNA therapies for the treatment of cystic fibrosis and genetic pulmonary diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2016 | Seed Round | - |
Integra Holdings Integra Holdings |
5/2021 | Series B | $0 |
Biotel Cystic Fibrosis Foundation Integra Holdings Israel Biotech Fund OrbiMed Biotel Cystic Fibrosis Foundation Integra Holdings Israel Biotech Fund OrbiMed |
5/2021 | Series B | 5 | $28.5M |
OrbiMed Israel Biotech Fund Cystic Fibrosis Foundation Integra Holdings Biotel Cystic Fibrosis Foundation Integra Holdings Israel Biotech Fund OrbiMed |
1/2016 | Seed Round | 1 | - |
Integra Holdings Integra Holdings |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|